Term
aqeuous humor flow through the |
|
Definition
|
|
Term
15% of aqeous humor leaves eye thru |
|
Definition
|
|
Term
this recpotr increase aqeous humor production |
|
Definition
|
|
Term
this recpto blocks outflow of aqeous humor |
|
Definition
|
|
Term
alpha 1 or 2 can block further release of NE |
|
Definition
|
|
Term
sympatheic system is respon for- |
|
Definition
|
|
Term
muscarinic AcH recpt leads to-4 |
|
Definition
contraction of ciliary muscle increase of trabecular flow miosis (pupil contraciton) -increase uveoscleral outflow |
|
|
Term
blockage of cillialry epithelium leads to- |
|
Definition
reduced secretion and reduced IOP |
|
|
Term
contraction of ciliary muscle leads to |
|
Definition
contraction by muscairnic cholinomimets-> reduced IOP |
|
|
Term
|
Definition
increase ocular bioavail reduce systemic absorption |
|
|
Term
|
Definition
|
|
Term
|
Definition
reduce aqueas humor secretion enhance aqeous outflow |
|
|
Term
agetns fro galucoma incerase- |
|
Definition
trabecular and uveoscelral outflows |
|
|
Term
agents for galucoma decrease |
|
Definition
|
|
Term
MOA of b blockers for galucoma |
|
Definition
decrease aqeous flow by blocking B2 |
|
|
Term
beta blockerds cna be topical |
|
Definition
|
|
Term
non selective b blockers for glaucoma |
|
Definition
timolol levbunolol metipranolol carteolol |
|
|
Term
the selective b1 blocker for glaucoma |
|
Definition
|
|
Term
local side effects of B blockers-2 |
|
Definition
|
|
Term
ssytimc ADES of beta blockers-2 |
|
Definition
|
|
Term
whihc ebta blockers have lower risk of bronchospasm and cardi effects-2 |
|
Definition
|
|
Term
to minimze systmic effects of beta blockers do what |
|
Definition
|
|
Term
b blockers are contraindcated in-7 |
|
Definition
lung dis sinus bradycard diabetes HF heart block athersclerosis therapy of oral beta blcoker |
|
|
Term
|
Definition
decrease aqeous humor production rate |
|
|
Term
blocking alpha 2 is like blocking beta 2 post synap |
|
Definition
|
|
Term
systemic side effects of alpha 2 agonists |
|
Definition
|
|
Term
what are the akpha 2 agonists |
|
Definition
|
|
Term
|
Definition
|
|
Term
brimonidine decrease _ and increases _ |
|
Definition
aqeous produciton uveoscerlal outflow |
|
|
Term
what is the first line alpha agoinst |
|
Definition
|
|
Term
MOA of prostoglandin F2 analogs |
|
Definition
increase uveoscleral outflow by 25%! |
|
|
Term
which drug class has really good efficacy and side effect profil? |
|
Definition
|
|
Term
local side effects of F2 analogs |
|
Definition
irreversible iris pigmentation |
|
|
Term
|
Definition
lantoprost travoprost bimatoprost |
|
|
Term
what are the 1st line tx fr galucoma |
|
Definition
F2 agoinsts (took over for b blockers) |
|
|
Term
MOA of carbonic anhyrase inhibitors |
|
Definition
decrease cililary body aqeous humor secretion (blocks Na and bicarb) |
|
|
Term
topical carbonic anhydrase inhibitors |
|
Definition
|
|
Term
systemic carboinc inhibitors, whjcih formulaitn are last line drugs why? |
|
Definition
systemic systemic acidosis mult drug interaction (AED, anti HTN |
|
|
Term
what are the systmic carboinc inhib-2 |
|
Definition
acetazolamide methazolamide |
|
|
Term
dont usesystmic and topical carboinc inhiitors togehter |
|
Definition
|
|
Term
MOA of cholinergic agents |
|
Definition
increase aqeous trabecular outflow-> reduce IOP |
|
|
Term
what are the cholinergic agents-3 |
|
Definition
pilocarpine carbachol chol inhibit |
|
|
Term
pilocarpine local side effects: systemic |
|
Definition
miois, spasm diarrhea, n.v |
|
|
Term
|
Definition
more freq an dsevere than pilocarpine |
|
|
Term
cholinesterase inhbiitors are limited use bc |
|
Definition
|
|
Term
what are hte cholinesterase inhibitors-2 |
|
Definition
|
|
Term
non specific adrenergic agonists MOA |
|
Definition
increase tubc an duvsceleor outflow |
|
|
Term
non specf adreng agonist- |
|
Definition
|
|
Term
what is the ester prodrug of epi:? |
|
Definition
|
|
Term
whihc is the adjunct drug |
|
Definition
|
|
Term
local side effects of dipivefin:2 |
|
Definition
|
|
Term
systemic side effects of dipivefrin:3 |
|
Definition
BP, tachycardia, headache |
|
|
Term
which drug can cause adrenochrome (depost pigment into conjuctiva na dcornea) |
|
Definition
|
|
Term
* can lead to trainset increase in IOP-> acute angle closure galucomea |
|
Definition
|
|
Term
look on slide 22 right befoer test for quick over view of all drugs |
|
Definition
|
|
Term
medicaiton for closed angle galucoma-4 *thse all used BEFORE surgery to reduce pressure |
|
Definition
secretory inhbiitors hyperosmotoc agent topical corticosterois pilocarpine |
|
|
Term
most common cause of blindness in elderly |
|
Definition
|
|
Term
*dry form mac deg dont have vision loss; |
|
Definition
|
|
Term
which is more the dry or wet form of mac deg |
|
Definition
|
|
Term
|
Definition
|
|
Term
non pharm tx for mac deg-3 |
|
Definition
quit smoking photodynamic therapy (lasers) trnaslocaiton surgery |
|
|
Term
angiogensis in wet mac deg is driven by |
|
Definition
|
|
Term
therapy for wet mac deg examples: |
|
Definition
VEGF anatags ranbizumab pegatanib bvacizumab |
|
|
Term
side effects of VEGF antagonists-3 |
|
Definition
eye hemorrhage immune resp intraocular inflamm |
|
|
Term
antioxidants used for mac deg; vitamins:5 |
|
Definition
C, E, zinc, copper, carotene |
|
|
Term
other anti oxidants fro mac deg |
|
Definition
|
|
Term
*cataracts= dead cells accum in lens capsule and make it clouded and yellow |
|
Definition
|
|
Term
|
Definition
mydriatics, anesthetics, ABX |
|
|
Term
|
Definition
ABX, anti inflamm, corticosteroids |
|
|
Term
Post surgery anti infalmm agents-2 |
|
Definition
NSAIDS (ketorolac, diclofenac) coritcosteroids (prednisolone) |
|
|
Term
post surgery cataracts ABX:2 |
|
Definition
fluroquinolone aminoglucosides |
|
|
Term
Tobradex= dexmethasone and tobramysone for catract post srugery |
|
Definition
|
|
Term
dry eye= evaporative or tear deficit |
|
Definition
|
|
Term
aritfical tears use what soln |
|
Definition
|
|
Term
opthalmic lubricants for dry eye are |
|
Definition
|
|
Term
opthalmic inserts for dry eye= |
|
Definition
|
|
Term
dry eye secretagogues:2 MOA? |
|
Definition
pilocarpine cevimelin M3 agonists |
|
|
Term
|
Definition
|
|